Affiliation:
1. Yaroslavl State Medical University, Yaroslavl, Russia
Abstract
During the long history of antibiotics, resistance of causative agents of main infectious diseases was estimated as a very serious threat to effective treatment of patients and as a social and economic problem faced by the entire mankind. The activities performed by the medical society provided no significant effect resulting in growing antibiotic resistance. The pandemic of novel coronavirus infection only made things worse. It became a new challenge for the medical community regarding searching solutions which are clinical, organizational and methodological by nature in the global struggle with resistance to antibiotics. The reviews of several studies of coronaviral infections have shown that treatment with antibiotics failed to correlate with the decreased all-cause mortality. In this work, we have reviewed some aspects of therapy with antibiotics, including ethical ones. Ethical aspects of antibiotic therapy concern decisions of physicians about administration of commonly unnecessary antimicrobial agents.
Publisher
Pirogov Russian National Research Medical University
Subject
Sociology and Political Science,Applied Psychology,Religious studies,Social Psychology,Animal Science and Zoology,Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine,Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy,Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine,Immunology and Allergy,Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine,Microbiology,Parasitology,Infectious Diseases,Microbiology (medical),Molecular Biology,Immunology,Immunology and Allergy,General Medicine,General Medicine,Pathology and Forensic Medicine
Reference22 articles.
1. O’Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. London: Review on Antimicrobial Resistance, 2014.
2. O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. London: Review on Antimicrobial Resistance, 2016.
3. de Kraker MEA, Stewardson AJ, Harbarth S (2016) Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? PLoS Med. 13 (11): e1002184.
4. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399: 629–55. Published Online January 20, 2022.
5. Chedid M, Waked R, Haddad E, Chetata N, Saliba G, Choucair J. Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy. J Infect Public Health. 2021 May; 14 (5): 570–576.